Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373896

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373896

Global Contraceptive Devices Market Size, Share, Growth Analysis, By Product(Condoms, Subdermal Implants), By End user(Male and Female) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).

To foster market growth, programs focused on reducing unintended pregnancies and associated healthcare costs and enhancing user awareness are anticipated. Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning, have been launched by governments and healthcare organizations to promote family planning and the manufacturing and utilization of contraceptives. Private and public sectors both play significant roles as providers of contraceptives. The private sector primarily supplies short-acting resupply contraceptive methods like condoms and contraceptive pills, consistently holding a considerable market share. In Asia, for instance, around 41% of females obtain contraceptives from private-sector sources, while approximately 56% rely on public sources. Across 36 evaluated countries categorized as low- and middle-income, about 63% of women acquire contraceptives from the private sector, whereas approximately 34% utilize public-sector sources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Contraceptive Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product, end user, and region. Based on Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Based on End user, the market is segmented into male and female. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptive Devices Market Dynamics

Drivers of the Global Contraceptive Devices Market

Development of a highly efficient

One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It's effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.

Restraints in the Global Contraceptive Devices

Market

Increasing risk of infections regarding the use of contraceptive devices

Contraceptive devices empower individuals to make informed choices about their reproductive health. By providing a reliable and accessible method of birth control, these devices promote reproductive autonomy and enable individuals to plan their families according to their personal circumstances. With a wide range of options available, including condoms, intrauterine devices (IUDs), and hormonal implants, contraceptive devices offer diverse choices to suit individual needs, fostering responsible sexual practices and reducing the risk of unintended pregnancies. Their availability promotes safer and healthier sexual experiences, ultimately empowering individuals to control their own reproductive journeys.

Market Trends of the Global Contraceptive Devices Key

The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.

Product Code: SQMIG35I2173

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Contraceptive Devices Market by Product
    • Market Overview
    • Condoms
    • Subdermal Implants
    • Contraceptive Drugs
    • Vaginal Rings
    • and Diaphragms
  • Global Contraceptive Devices Market by End user
    • Market Overview
    • Male and Female
  • Global Contraceptive Devices Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Janssen Global Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck Sharp & Dohme Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Reckitt Benckiser Group plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Veru Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CooperSurgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Devex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mayer Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Agile Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • HLL Lifecare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • ANSELL LTD (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mankind Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • TTK HealthCare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim International GmbH. (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • V-Care Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!